5 Most Valuable Companies in Europe

2. Roche Holdings AG (OTCMKTS:RHHBY)

Market Cap: $322 billion
Revenue: $65.88 billion

Another pharmaceutical company that has made the list  of most valuable companies in Europe is Roche Holdings AG (OTCMKTS:RHHBY), which is based in Switzerland. The company develops pharmaceutical products for the treatment of different illnesses such as cancer, anemia, hepatitis, HIV/AIDs etc.

Roche Holdings AG (OTCMKTS:RHHBY) was established in 1896 and has since established itself as one of the most valuable companies in Europe with a market cap of over $331.763 billion. Recently, Roche was granted the FDA approval for its arthritis drug Actemra for emergency use in the treatment of the coronavirus.

Roche Holdings AG (OTCMKTS:RHHBY) also recently signed a merger agreement with GenMark Diagnostics worth $1.8 billion.

Brown Capital Management highlighted Roche Holdings AG (OTCMKTS:RHHBY) in its Q4 2020 investor letter. Here is what the fund said:

“We eliminated Roche Holdings, a Switzerland-based company that is the largest biotech in the world. While the company is on the cutting edge of drug discovery, particularly in cancer-related treatments, it is facing an uncertain growth path and pressure from generics in its mature drugs. Roche has been a positive contributor to the portfolio since its introduction more than a decade ago, and we now take the opportunity to recycle the capital into higher-growth companies.”